Anzeige
Mehr »
Dienstag, 23.09.2025 - Börsentäglich über 12.000 News
Der nächste große KI-Durchbruch in der Frauengesundheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A112C8 | ISIN: FR0010120402 | Ticker-Symbol: 941
München
22.09.25 | 08:01
0,848 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERACLION Chart 1 Jahr
5-Tage-Chart
THERACLION 5-Tage-Chart
RealtimeGeldBriefZeit
0,8240,86022.09.

Aktuelle News zur THERACLION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.09.Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate192Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915148081/en/Sonovein redefines varicose vein treatment with advanced...
► Artikel lesen
25.07.Theraclion Growth Up in S1 2025506Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250725366467/en/Sonovein®, the first and only non-invasive varicose veins...
► Artikel lesen
29.04.Theraclion Announces Financial Results 2024 and Reviews Progress417Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces...
► Artikel lesen
26.03.Theraclion Completes Its Previous Financing Round With an Additional Convertible Bonds Issuance471Issuance of warrants for bonds convertible into shares, in accordance with Theraclion's commitment, to investors who have requested them, for a maximum amount of 580,000 euros. 290,000...
► Artikel lesen
THERACLION Aktie jetzt für 0€ handeln
20.02.Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan640Reserved issuance of warrants for convertible bonds based on a fixed price per share of 0.20 euros (without discount), for a maximum amount of €6 million, benefiting Furui and Unigestion, the...
► Artikel lesen
11.02.Theraclion Announces Treatment of First Patients With New SONOVEIN 'SpeedPulse' Feature Accelerating Treatment443Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces...
► Artikel lesen
07.02.Theraclion: Publication of Adjusted Accounts for the First Half of 2024545Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment...
► Artikel lesen
06.01.Theraclion Reviews Its 2024 Achievements352Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment...
► Artikel lesen
30.10.24Theraclion Announces Major Advances and Reports First-Half Financial Results528On the strength of its progress on its 2023 and 2024 priorities (access to the US market, R&D and China), Theraclion is planning its commercial ramp-up for 2025 and 2026. Pivotal study for...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1